(Q34138056)

31 July 2017

title

CIP2A is overexpressed in non-small cell lung cancer and correlates with poor prognosis (English)

1 reference

non-small-cell lung carcinoma

31 July 2017

1 reference

1 reference

Qian-Ze Dong

1

1 reference

31 July 2017

Yang Wang

2

1 reference

31 July 2017

Xin-Jun Dong

3

1 reference

31 July 2017

Zi-Xuan Li

4

1 reference

31 July 2017

Zhong-Ping Tang

5

1 reference

31 July 2017

Quan-Ze Cui

6

1 reference

31 July 2017

En-Hua Wang

7

1 reference

31 July 2017

publication date

15 September 2010

1 reference

Annals of Surgical Oncology

31 July 2017

published in

1 reference

31 July 2017

volume

18

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

857-865

1 reference

Non-small-cell lung cancer vaccine therapy: a concise review

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1313-8

Erlotinib in previously treated non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1313-8

Erlotinib in lung cancer - molecular and clinical predictors of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1313-8

Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1313-8

CIP2A inhibits PP2A in human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1313-8

MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1313-8

CIP2A is associated with human breast cancer aggressivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1313-8

A tumor suppressor role for PP2A-B56alpha through negative regulation of c-Myc and other key oncoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1313-8

Mechanisms of MYC stabilization in human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1313-8

A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1313-8

Function of the c-Myc oncogenic transcription factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1313-8

Patterns of methylation of the c-myc gene in human colorectal cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1313-8

Relationship of c-myc amplification to progression of breast cancer from in situ to invasive tumor and lymph node metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1313-8

Wnt1 overexpression promotes tumour progression in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1313-8

10.1245/S10434-010-1313-8

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1032243156

0 references

1 reference